Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This prospective, observational study aim to identify :
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Survival | at day 0 | |
| Survival | at 6 months | |
| Survival | at 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Neurological outcome with the Glasgow Coma Scale (GCS) score | at day 0 | |
| Neurological outcome with the Glasgow Coma Scale (GCS) score | at 6 months | |
| Neurological outcome with the Glasgow Coma Scale (GCS) score |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All patients admitted to the unit of investigator with subarachnoid hemorrhage, whatever the etiology, is included in their prospective registry
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Frédéric DAILLER, MD | Contact | 4 72 35 75 76 | +33 | frederic.dailler@chu-lyon.fr |
| Name | Affiliation | Role |
|---|---|---|
| Frédéric DAILLER, MD | Service de réanimation neurologique Hospices Civils de Lyon | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Service de réanimation polyvalente neurologique Hôpital Neurologique HCL | Recruiting | Bron | 69500 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39448701 | Derived | Chardon N, Nourredine M, Ledochowski S, Kurland NT, Dailler F, Ritzenthaler T, Nougier C, Balanca B. Trajectory of mean platelet volume changes after aneurysmal subarachnoid hemorrhage in patients with or without delayed cerebral ischemia. Sci Rep. 2024 Oct 24;14(1):25122. doi: 10.1038/s41598-024-75587-8. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013345 | Subarachnoid Hemorrhage |
| ID | Term |
|---|---|
| D020300 | Intracranial Hemorrhages |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| at 12 months |
| Neuropsychological outcome with the Montreal Cognitive Assessment (MoCA) score | at day 0 |
| Neuropsychological outcome with the Montreal Cognitive Assessment (MoCA) score | at 6 months |
| Neuropsychological outcome with the Montreal Cognitive Assessment (MoCA) score | at 12 months |
| Brain lesions with MRI | at day 0 |
| Brain lesions with MRI | at 6 months |
| Brain lesions with MRI | at 12 months |
| delay of apparition of hyponatremia | Natremia in standard blood sample, Natremia is routinelly evaluated on alternte days, and more if required. | on alternte days after Day 0 |
| D009422 | Nervous System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D006470 | Hemorrhage |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |